Wegovy Lifespan: How Long Does Treatment Actually Last?

The misconception: Wegovy is a short-term fix with a natural finishing point

The most common misunderstanding about the lifespan of Wegovy treatment is that there is a standard course, after which the medicine has done its job and can be stopped. That framing is borrowed from how people think about, say, a course of antibiotics. It does not apply here.

Semaglutide works by acting on GLP-1 receptors involved in appetite regulation and gastric emptying. While the medicine is active, it suppresses appetite and supports weight loss. When it stops, those effects stop too. The STEP 1 trial, published in the New England Journal of Medicine, showed that participants who completed 68 weeks of treatment and then stopped regained most of the weight within a year. The biology of obesity does not switch off at the end of a course.

That is not a failure of the medicine. It reflects the nature of weight as a chronic, biologically driven condition. The realistic framing is that Wegovy manages a condition rather than cures it, which has direct implications for how long treatment might last and what planning needs to happen alongside it.

If you are weighing up whether semaglutide is the right option at all, the semaglutide overview covers how it works, what the evidence shows, and who it is licensed for in the UK.

What NICE and NHS guidance actually set as the time limit

For NHS patients, there is a defined upper boundary. NICE's appraisal of semaglutide (TA875) recommends it for a maximum of two years, within a specialist weight management service that includes multidisciplinary support. This is not an arbitrary cut-off; it reflects both the duration of available trial data at the time of appraisal and a commissioning decision about long-term NHS resource use.

There is also a six-month checkpoint built into NICE guidance. If someone has not lost at least 5% of their body weight after six months on the maintenance dose, the recommendation is to review whether continuing is appropriate. That checkpoint exists on both the NHS and in responsible private prescribing.

The ethnic-background BMI thresholds that affect eligibility (2.5 kg/m² lower for South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds) are set out in the NHS England guidance on weight-management injections, which is also worth reading for context on what wraparound support the NHS expects alongside any GLP-1 treatment.

For private patients, the two-year NHS cap does not automatically apply, duration is a clinical decision made between prescriber and patient, shaped by ongoing response, health changes, and whether the risks and benefits continue to balance positively.

The six-month checkpoint (and how to use it practically

One practical habit worth building into your treatment from the start: weigh yourself consistently and record it) the same time of day, same scales, once a week. It takes under a minute, and over months it gives your prescriber something concrete to work from at review. A gradual downward trend across weeks matters far more than any single reading.

That six-month mark on the maintenance dose is the clearest signal in the guidance. It is the point at which a prescriber can say with reasonable confidence whether semaglutide is working for this person. If it is, the case for continuing is strong. If weight has barely shifted, a different approach may be more useful than persisting indefinitely.

Questions about what happens after an extended period on Wegovy, or what stopping looks like in practice, are covered in more depth on the life after Wegovy page, which looks at what the evidence says about the transition off treatment and how to approach it sensibly.

Cost, the long view, and what treatment actually includes

Duration has obvious implications for cost. Private treatment that runs for a year or longer is a significant financial commitment, and it is worth understanding what that price covers before starting. At nume, the price includes the consultation, prescription, next-working-day tracked delivery, and aftercare support, there are no separate prescription or admin fees, and no subscription that renews without your say-so. Every repeat order goes through a fresh clinical review. If you want to understand the cost landscape before committing, the weight-loss treatment overview sets out the full picture.

For anyone thinking about whether Wegovy is something they might take indefinitely, whether you are on Wegovy for life has a genuinely nuanced answer, one that turns on individual health circumstances rather than a blanket yes or no. Similarly, the question of whether Wegovy is a lifelong medicine is addressed in depth elsewhere, including what happens to the weight-management benefits over a very long treatment course.

Whatever duration ends up being right for you, that decision belongs with a prescriber who knows your case. If you would like to have that conversation with our clinical team, checking your eligibility is the first step.